
iHuman Inc.: updates and filings
Price
$0.78
November 20, 2026Market cap $40M
What Ploutos Investor adds for iHuman
Part of Ploutos Investor, €9.99 a month
- The full history: 8 fiscal years, from 2018
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The reported profit is far larger than a business usually earns on its market value, which usually means one-off or accounting gains. We leave out the P/E and the earnings yield.
- Profit over the last twelve months is well above what the business itself earned, because it includes large gains outside the business, such as on investments or from selling a business. The P/E is lower than the business alone would give.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Sep 29, 2026Current report (foreign company)Form6-K
- Jun 29, 2026Current report (foreign company)Form6-K
- Jun 1, 2026Current report (foreign company)Form6-K
- Apr 24, 2026Annual report (foreign company)for the period to Dec 31, 2025Form20-F
- Mar 31, 2026Current report (foreign company)Form6-K
- Dec 29, 2025Current report (foreign company)Form6-K
- Sep 18, 2025Current report (foreign company)Form6-K
- Jun 26, 2025Current report (foreign company)Form6-K
- Apr 28, 2025Annual report (foreign company)for the period to Dec 31, 2024Form20-F
- Mar 25, 2025Current report (foreign company)Form6-K
- Dec 26, 2024Current report (foreign company)Form6-K
- Oct 31, 2024Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 31, 2024Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Sep 27, 2024Current report (foreign company)Form6-K
- Jun 28, 2024Current report (foreign company)Form6-K
- May 24, 2024Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Apr 25, 2024Annual report (foreign company)for the period to Dec 31, 2023Form20-F
- Feb 29, 2024Current report (foreign company)Form6-K
- Feb 8, 2024Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jan 3, 2024Letter from the SECFormUPLOAD
- Dec 28, 2023Current report (foreign company)Form6-K
- Dec 1, 2023Correspondence with the SECFormCORRESP
- Nov 16, 2023Letter from the SECFormUPLOAD
- Oct 24, 2023Correspondence with the SECFormCORRESP
- Sep 28, 2023Correspondence with the SECFormCORRESP
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Sep 29, 2026 | 6-K | Current report (foreign company) | Document |
| Jun 29, 2026 | 6-K | Current report (foreign company) | Document |
| Jun 1, 2026 | 6-K | Current report (foreign company) | Document |
| Apr 24, 2026 | 20-F | Annual report (foreign company)for the period to Dec 31, 2025 | Document |
| Mar 31, 2026 | 6-K | Current report (foreign company) | Document |
| Dec 29, 2025 | 6-K | Current report (foreign company) | Document |
| Sep 18, 2025 | 6-K | Current report (foreign company) | Document |
| Jun 26, 2025 | 6-K | Current report (foreign company) | Document |
| Apr 28, 2025 | 20-F | Annual report (foreign company)for the period to Dec 31, 2024 | Document |
| Mar 25, 2025 | 6-K | Current report (foreign company) | Document |
| Dec 26, 2024 | 6-K | Current report (foreign company) | Document |
| Oct 31, 2024 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 31, 2024 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Sep 27, 2024 | 6-K | Current report (foreign company) | Document |
| Jun 28, 2024 | 6-K | Current report (foreign company) | Document |
| May 24, 2024 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Apr 25, 2024 | 20-F | Annual report (foreign company)for the period to Dec 31, 2023 | Document |
| Feb 29, 2024 | 6-K | Current report (foreign company) | Document |
| Feb 8, 2024 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jan 3, 2024 | UPLOAD | Letter from the SEC | Document |
| Dec 28, 2023 | 6-K | Current report (foreign company) | Document |
| Dec 1, 2023 | CORRESP | Correspondence with the SEC | Document |
| Nov 16, 2023 | UPLOAD | Letter from the SEC | Document |
| Oct 24, 2023 | CORRESP | Correspondence with the SEC | Document |
| Sep 28, 2023 | CORRESP | Correspondence with the SEC | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jun 26, 2020.
The full analysis
What do iHuman's filings show?
The filings are where every one of iHuman's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.